VERTO MD is a privately held service-providing company specializing in clinical research and development in the field of medical sciences and biotechnology, as well as the development, management, and monitoring of clinical trials. The main VERTO MD therapeutic areas include immunology and oncology, having experience in indications including but not limited to niche or orphan indications like CD37+, CD123+, CD70+, CD30+, CD33+, CD19+, CD20+, CD3+, expressing malignancies, FcRn, PD-1/PDL-1, single and multi targeting therapeutics, NOTCH signaling, TNFs, HDAC inhibition, proteasome inhibitors.…
Annual Revenue$1M to $5M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.